Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1157 | 1066 | 1178 | 1531 | 1508 | 2574 |
Fund Return | 15.69% | 6.63% | 17.77% | 15.26% | 8.56% | 9.92% |
Place in category | 285 | 365 | 399 | 645 | 392 | 260 |
% in Category | 13 | 18 | 21 | 37 | 28 | 30 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Swedbank Robur Technology | 165.86B | 13.73 | 22.42 | 25.11 | ||
Swedbank Robur IP Aktiefond | 72.87B | 10.71 | 19.37 | 18.13 | ||
SE0013109519 | 58.88B | 19.51 | 24.39 | 17.64 | ||
Swedbank Robur Allemansfond Komple | 103.66B | 22.01 | 16.13 | 12.64 | ||
Swedbank Robur Aktiefond Pension | 86.12B | 14.38 | 16.22 | 12.15 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Handelsbanken Europafond Index | 18.73B | 12.82 | 12.43 | 9.45 | ||
Handelsbanken European Index utd | 18.73B | 12.82 | 12.43 | 8.97 | ||
SPP Aktiefond Europa | 17.54B | 13.77 | 12.48 | 9.29 | ||
FI4000048988 | 10.86B | 13.57 | 10.92 | 9.87 | ||
Lansforsakringar Europa Indexnara | 10.65B | 13.21 | 12.04 | 9.05 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 3.63 | 95.60 | -2.47% | |
ASML Holding | NL0010273215 | 3.02 | 963.40 | +0.47% | |
Novo Nordisk A/S Class B | DK0060534915 | 2.67 | - | - | |
Roche Holding Participation | CH0012032048 | 2.64 | 239.70 | -1.20% | |
AstraZeneca | GB0009895292 | 2.38 | 12,600.0 | +0.35% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review